Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Browse Databases and Tools

Sort by Show per page
  • Nutrition support for bone marrow transplant patients
    Cochrane Systematic Reviews, 23-Mar-2017
  • Nutritional interventions for preventing and treating pressure ulcers
    Cochrane Systematic Reviews, 12-Jun-2014
  • Nutritional supplementation for hip fracture aftercare in older people
    Cochrane Systematic Reviews, 30-Nov-2016
  • Nutritional support for critically ill children
    Cochrane Systematic Reviews, 27-May-2016
  • Nutritional support for head‐injured patients
    Cochrane Systematic Reviews, 18-Oct-2006
  • Nutritional support in children and young people with cancer undergoing chemotherapy
    Cochrane Systematic Reviews, 24-Aug-2015
  • Nystatin prophylaxis and treatment in severely immunodepressed patients
    Cochrane Systematic Reviews, 4-Sep-2014
  • Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution
    Cochrane Systematic Reviews, 14-Mar-2011
  • Olanzapine alone or in combination for acute mania
    Cochrane Systematic Reviews, 20-Jan-2003
  • Omega‐3 fatty acid supplementation for cystic fibrosis
    Cochrane Systematic Reviews, 10-Apr-2020
  • Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus
    Cochrane Systematic Reviews, 4-Nov-2008
  • Once‐daily versus multiple‐daily dosing with intravenous aminoglycosides for cystic fibrosis
    Cochrane Systematic Reviews, 4-Sep-2019
  • Opioids for neuropathic pain
    Cochrane Systematic Reviews, 29-Aug-2013
  • Oral anti‐pseudomonal antibiotics for cystic fibrosis
    Cochrane Systematic Reviews, 14-Jul-2016
  • Oral calorie supplements for cystic fibrosis
    Cochrane Systematic Reviews, 4-May-2017
  • Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis
    Cochrane Systematic Reviews, 9-Sep-2019
  • Oral protein calorie supplementation for children with chronic disease
    Cochrane Systematic Reviews, 27-May-2015
  • Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions
    Cochrane Systematic Reviews, 7-Dec-2011
  • Oral steroids for long‐term use in cystic fibrosis
    Cochrane Systematic Reviews, 9-Dec-2015
  • Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children
    Cochrane Systematic Reviews, 19-Jul-2006

Login or Subscribe


Not Yet a Subscriber?

Doctor with handheld

We offer subscriptions for individuals and institutions

To find out about all the benefits of a year-long subscription to Essential Evidence Plus, click the button below!

Learn More